Endocrine Abstracts

Introduction: Racism is a fundamental determinant of health, described by Prof Kevin Fenton (PHE) as a "wicked problem"- a complex problem highly resistant to solutions. The amplification of the voice of black lives matter” and disproportionate number of deaths from Covid-19 in Black and Asian people has re-focussed attention on racial health inequalities. Structural racism and unconscious bias is present throughout medicine. The National Paediatric Diabetes Audit...

Introduction: Diabetic Ketoacidosis (DKA) is a common complication of Type 1 Diabetes (T1DM), accounting for around 21% of all diabetes related admissions. It is a major source of morbidity and mortality amongst children with T1DM. Delayed diagnosis, shock, renal failure, cerebral oedema and sepsis remain problematic. The aim of this project was to compare local management to best practice as per the British Society for Paediatric Endocrinology and Diabetes (BSPED), and provid...

Introduction: Structured education is an integral part of type one diabetes care for children and young people and their families, delivered at diagnosis. There is currently no validated curriculum or outcome measures of diabetes education in the UK. We evaluated the outcome of using the diabetes education app (deapp), using flipped learning against historical practice, to determine if it conferred any benefit in our single centre.Methods: Two cohorts of...

Introduction: Congenital hypothyroidism (CHT) is a significant health issue, responsible for serious long-term consequences if left untreated. From experience we know that early identification and treatment can prevent long-term neurodevelopmental sequelae of the condition. We audited our management of babies born with CHT between the years of 2012 and 2019 to evaluate our care against best practice.Methods: Babies born with CHT in Nottingham between 201...

Introduction: Type 1 diabetes (T1D) onset may start years prior to clinical presentation. Screening children and young people (CYP) for T1D using islet autoantibodies (IAb) through research studies is gaining international momentum, since screening reduces diabetic ketoacidosis, hospitalisation and offers access to drug therapies for delaying T1D onset1. Recently, ISPAD provided recommendations on monitoring for pre-clinical T1D in CYP, however no U...